Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $48.81 USD
Change Today +0.99 / 2.07%
Volume 694.1K
ACAD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 4:00 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas H. Aasen CPA

Former Chief Financial Officer, Chief Business Officer, Principal Accounting Officer, Executive Vice President and Treasurer, ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54$184,739
As of Fiscal Year 2014

Background*

Mr. Thomas H. Aasen, CPA served as the Chief Financial Officer and Treasurer of Acadia Pharmaceuticals Inc. since April 1998 and served as its Principal Accounting Officer, Chief Business Officer and Executive Vice President. Mr. Aasen served as a Secretary of Acadia Pharmaceuticals Inc. From June 1996 to April 1998. He served as Vice President of Acadia Pharmaceuticals Inc. since April 1998. He held the position of Senior Director for Finance and Administration of Axys ...

Read Full Background

Corporate Headquarters*

3611 Valley Centre Drive
San Diego, California 92130

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
San Diego State University

Other Affiliations*

Annual Compensation*

Salary$152,299
Total Annual Compensation$152,299

Stock Options*

All Other Compensation$32,440
Exercised Options523,085
Exercised Options Value$10,267,729
Exercisable Options58,217
Total Value of Options$10,267,729
Total Number of Options581,302

Total Compensation*

Total Annual Cash Compensation$184,739
Total Short Term Compensation$152,299
Other Long Term Compensation$32,440
Total Calculated Compensation$184,739
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACAD:US $48.81 USD +0.99

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$745.8K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACADIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.